Unlocking the biology of RAGE in diabetic microvascular complications

Area of Science:

• Biomedical Science
• Molecular Biology
• Endocrinology

Background:

• The receptor for advanced glycation end-products (RAGE) plays a key role in cellular signaling.
• RAGE ligands, including advanced glycation end-products (AGEs), S100/calgranulins, and high mobility group box 1 (HMGB1), are implicated in inflammatory processes.
• The involvement of inflammatory pathways in diabetic complications is increasingly recognized.

Purpose of the Study:

• To review the biological mechanisms of RAGE signal transduction.
• To elucidate the role of RAGE in the pathogenesis of diabetic microvascular complications.
• To synthesize evidence from animal models and human studies regarding RAGE and diabetes.

Main Methods:

• Literature review of studies on RAGE biology and diabetic complications.
• Analysis of experimental data from animal models and human subjects.
• Synthesis of findings related to ligand-RAGE interactions and vascular effects.

Main Results:

• RAGE transduces signals from various ligands, including AGEs, S100/calgranulins, and HMGB1.
• These ligand-RAGE interactions contribute to vascular perturbation and inflammation.
• Evidence supports the role of RAGE signaling in the development of diabetic microvascular complications.

Conclusions:

• RAGE signaling is a significant pathway in the development of diabetic complications.
• Understanding RAGE biology is essential for developing therapeutic strategies for diabetic vascular disease.
• Further research in both preclinical models and human studies is warranted to fully explore RAGE's role.